Status:
COMPLETED
Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
Lead Sponsor:
Asan Medical Center
Conditions:
Gastrointestinal Stromal Tumors
Eligibility:
All Genders
15+ years
Brief Summary
In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1 month of nilotinib treatment. The relationship between surgery type and nilotinib pharmakokinetic properties w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with metastatic or unresectable gastrointestinal stromal tumor
- Patients receiving nilotinib after failure to imatinib and sunitinib
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00976612
Start Date
January 1 2009
End Date
December 1 2011
Last Update
January 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736